Trinity Biotech plc
TRIB
$0.35
$0.000.91%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 61.56M | 59.13M | 69.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 61.56M | 59.13M | 69.37M |
| Cost of Revenue | -- | -- | 40.12M | 38.00M | 49.29M |
| Gross Profit | -- | -- | 21.44M | 21.13M | 20.08M |
| SG&A Expenses | -- | -- | 28.82M | 27.38M | 23.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 1.79M | -42.00K | 2.94M |
| Total Operating Expenses | -- | -- | 75.26M | 69.54M | 79.57M |
| Operating Income | -- | -- | -13.70M | -10.41M | -10.21M |
| Income Before Tax | -- | -- | -30.73M | -20.43M | -35.37M |
| Income Tax Expenses | -- | -- | 486.00K | -102.00K | -1.37M |
| Earnings from Continuing Operations | -- | -- | -31.22 | -20.33 | -34.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -3.00K | 1.81M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -31.79M | -20.33M | -32.20M |
| EBIT | -- | -- | -13.70M | -10.41M | -10.21M |
| EBITDA | -- | -- | -13.03M | -8.51M | -9.26M |
| EPS Basic | -- | -- | -35.35 | -45.27 | -108.08 |
| Normalized Basic EPS | -- | -- | -0.30 | -0.30 | -0.53 |
| EPS Diluted | -- | -- | -40.08 | -45.79 | -108.06 |
| Normalized Diluted EPS | -- | -- | -0.30 | -0.30 | -0.53 |
| Average Basic Shares Outstanding | -- | -- | 46.68M | 36.38M | 23.51M |
| Average Diluted Shares Outstanding | -- | -- | 2.33M | 1.82M | 1.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |